Founded in 2016 by leading microbiome experts, RondinX has built a cutting-edge microbiome technology platform set to unlock the potential of microbiome therapeutics. RondinX technology, including its PTR (Peak-to-Trough) family of algorithms, exclusively licensed from YEDA (the commercial arm of the Weizmann Institute of Science), is a proprietary, cloud-based, computational pipeline, integrating raw metagenomics, other omics and patient metadata to derive both static and dynamic strain level insights into the bacterial ecosystem
Company Details
- Founded
- -
- Address
- Tel Aviv, Tel Aviv,israel
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.rondinx.com
- HQ
- Tel Aviv
Rondinx Questions
Rondinx's website is http://www.rondinx.com
Rondinx's LinkedIn profile is https://il.linkedin.com/company/rondinx
Rondinx's industry is
Pharmaceutical Manufacturing
Rondinx's top competitors are
Epm Group Inc.,
Nanopure,
Anatomy Medical Technologies,
Ela Pharma Ltd.,
Konikoff Medical,
Cavos Biotherapeutics,
Biomx (Nyse: Phge),
Virucure Therapeutics,
Gammacell Bio-Technologies Ltd.,
Gna Research Ltd..
Rondinx's categories are Pharmaceutical Manufacturing
Rondinx's founding year is 2016
